This study is aimed at employing bioinformatics to investigate and comprehend the expression of PLAU and CTSK in pancreatic cancer, as well as their relationship with clinicopathological and prognostic significance, underlying molecular mechanisms, and immune cell infiltration, to aid physicians. This evidence concerns the gene CTSK and familial pancreatic carcinoma.